GGrantIndex
← Leaderboards

James R Lokensgard

University Of Minnesota

$16,261,665
Attributed
$16,261,665
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.2M · FY200523
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$16,261,665 · 4

By mechanism

R01$16,079,242 · 3
R29$182,423 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Minnesota

Same institution · by research overlap

Others in their field

Top investigators on “Brain

Research focus

BrainVirus DiseasesCellsMicrogliaIn VitroViralResponseInfectionMediatingKnockout AnimalIn VivoRegulatory T-LymphocyteT-LymphocyteCytokineNeuronsProteinsAnimalsVirusFundingAstrocytesTransgenic MiceDiphtheria Toxin ReceptorNeurogliaImmune

Grant awards (51)

Immunotherapy to enhance anti-HIV-1 responses against viral brain infection$385,000
R01 · FY2023 · MH · contact PI
Anti-HIV-1 recall responses from brain-resident memory CD8+ T-cells (bTRM) and reactive gliosis-mediated neurotoxicity$385,000
R01 · FY2022 · NS · contact PI
Immunotherapy to enhance anti-HIV-1 responses against viral brain infection$385,000
R01 · FY2022 · MH · contact PI
Anti-HIV-1 recall responses from brain-resident memory CD8+ T-cells (bTRM) and reactive gliosis-mediated neurotoxicity$385,000
R01 · FY2021 · NS · contact PI
Immunotherapy to enhance anti-HIV-1 responses against viral brain infection$385,000
R01 · FY2021 · MH · contact PI
Immunotherapy to enhance anti-HIV-1 responses against viral brain infection$385,000
R01 · FY2020 · MH · contact PI
Neuroimmune Approaches to Retrovirus Infection-induced Neuropathy via CB2Rs$385,000
R01 · FY2020 · DA · contact PI
Anti-HIV-1 recall responses from brain-resident memory CD8+ T-cells (bTRM) and reactive gliosis-mediated neurotoxicity$385,000
R01 · FY2020 · NS · contact PI
Anti-HIV-1 recall responses from brain-resident memory CD8+ T-cells (bTRM) and reactive gliosis-mediated neurotoxicity$385,000
R01 · FY2019 · NS · contact PI
Neuroimmune Approaches to Retrovirus Infection-induced Neuropathy via CB2Rs$385,000
R01 · FY2019 · DA · contact PI
Immunotherapy to enhance anti-HIV-1 responses against viral brain infection$385,000
R01 · FY2019 · MH · contact PI
Neuroimmune Approaches to Retrovirus Infection-induced Neuropathy via CB2Rs$384,791
R01 · FY2018 · DA · contact PI
Anti-HIV-1 recall responses from brain-resident memory CD8+ T-cells (bTRM) and reactive gliosis-mediated neurotoxicity$383,761
R01 · FY2018 · NS · contact PI
Neuroimmune Approaches to Retrovirus Infection-induced Neuropathy via CB2Rs$382,292
R01 · FY2017 · DA · contact PI
T lymphocyte-induced glial activation during CNS immune reconstitution disease$380,000
R01 · FY2017 · MH · contact PI
Role of B-cells and CNS antibodies in modulating chronic microglial activation$380,000
R01 · FY2017 · NS · contact PI
T lymphocyte-induced glial activation during CNS immune reconstitution disease$380,000
R01 · FY2016 · MH · contact PI
Neuroimmune Approaches to Retrovirus Infection-induced Neuropathy via CB2Rs$380,000
R01 · FY2016 · DA · contact PI
Role of B-cells and CNS antibodies in modulating chronic microglial activation$380,000
R01 · FY2016 · NS · contact PI
T lymphocyte-induced glial activation during CNS immune reconstitution disease$380,000
R01 · FY2015 · MH · contact PI
Role of B-cells and CNS antibodies in modulating chronic microglial activation$380,000
R01 · FY2015 · NS · contact PI
T lymphocyte-induced glial activation during CNS immune reconstitution disease$380,000
R01 · FY2014 · MH · contact PI
Role of B-cells and CNS antibodies in modulating chronic microglial activation$376,200
R01 · FY2014 · NS · contact PI
T lymphocyte-induced glial activation during CNS immune reconstitution disease$380,000
R01 · FY2013 · MH · contact PI
Role of B-cells and CNS antibodies in modulating chronic microglial activation$380,000
R01 · FY2013 · NS · contact PI
Immunoregulation of herpes encephalitis by microglia$355,039
R01 · FY2012 · MH · contact PI
Defense mechanisms against CMV brain infection$323,706
R01 · FY2012 · NS · contact PI
Immunoregulation of herpes encephalitis by microglia$355,039
R01 · FY2011 · MH · contact PI
Defense mechanisms against CMV brain infection$323,706
R01 · FY2011 · NS · contact PI
Immunoregulation of herpes encephalitis by microglia$358,625
R01 · FY2010 · MH · contact PI
Defense mechanisms against CMV brain infection$327,010
R01 · FY2010 · NS · contact PI
Immunoregulation of herpes encephalitis by microglia$358,625
R01 · FY2009 · MH · contact PI
Defense mechanisms against CMV brain infection$330,313
R01 · FY2009 · NS · contact PI
Immunoregulation of herpes encephalitis by microglia$377,500
R01 · FY2008 · MH · contact PI
Defense mechanisms against CMV brain infection$330,313
R01 · FY2008 · NS · contact PI
Defense Mechanisms Against CMV Brain Infection$262,244
R01 · FY2007 · NS · contact PI
Immunoregulation of Herpes Encephalitis By Microglia$248,068
R01 · FY2007 · MH · contact PI
Defense Mechanisms Against CMV Brain Infection$270,076
R01 · FY2006 · NS · contact PI
Immunoregulation of Herpes Encephalitis By Microglia$255,477
R01 · FY2006 · MH · contact PI
Defense Mechanisms Against CMV Brain Infection$256,403
R01 · FY2005 · NS
Immunoregulation of Herpes Encephalitis By Microglia$155,654
R01 · FY2005 · MH
Immunoregulation of Herpes Encephalitis By Microglia$106,220
R01 · FY2005 · MH
Defense Mechanisms Against CMV Brain Infection$254,323
R01 · FY2004 · NS
Immunoregulation of Herpes Encephalitis By Microglia$234,063
R01 · FY2004 · MH
Immunoregulation of Herpes Encephalitis By Microglia$232,343
R01 · FY2003 · MH
DEFENSE MECHANISMS FOR CYTOMEGALOVIRUS BRAIN INFECTION$208,109
R01 · FY2003 · NS
DEFENSE MECHANISMS FOR CYTOMEGALOVIRUS BRAIN INFECTION$202,050
R01 · FY2002 · NS
DEFENSE MECHANISMS FOR CYTOMEGALOVIRUS BRAIN INFECTION$196,165
R01 · FY2001 · NS
ANXIOLYTIC DRUGS EFFECTS ON HIV1 NEUROPATHOGENESIS$91,525
R29 · FY2001 · MH
DEFENSE MECHANISMS FOR CYTOMEGALOVIRUS BRAIN INFECTION$196,127
R01 · FY2000 · NS
ANXIOLYTIC DRUGS EFFECTS ON HIV1 NEUROPATHOGENESIS$90,898
R29 · FY2000 · MH